Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/16/2003CA2481318A1 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
10/16/2003CA2481090A1 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003CA2481039A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480996A1 Peptides derived or obtained from cytokine and the application thereof in therapy
10/16/2003CA2480811A1 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
10/16/2003CA2480786A1 Recombinant p. falciparum merozoite protein-142 vaccine
10/16/2003CA2480692A1 Chemokines mutants having improved oral bioavailability
10/16/2003CA2480598A1 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
10/16/2003CA2480504A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
10/16/2003CA2480450A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480084A1 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003CA2479049A1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
10/16/2003CA2478930A1 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003CA2477935A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003CA2477421A1 Novel promoter
10/15/2003EP1352975A2 Selection of sites for targeting by zinc finger proteins and methods of designing zinc fingers proteins to binds to preselected sites
10/15/2003EP1352962A1 186 human secreted proteins
10/15/2003EP1352961A1 Synovial cell protein
10/15/2003EP1352958A1 Gene disrupted yeast
10/15/2003EP1352912A1 Parathyroid hormone analogues for the treatment of osteoporosis
10/15/2003EP1352911A1 Angiotensin converting enzyme inhibitors
10/15/2003EP1352656A2 Combination therapy using a TNF binding protein for treating TNF-mediated diseases
10/15/2003EP1352242A2 Detection methods
10/15/2003EP1352240A2 Cloning and expression of a new mcp receptor in glial cells
10/15/2003EP1352092A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/15/2003EP1352091A2 Compositions and methods enabling a totally internally controlled amplification reaction
10/15/2003EP1352077A2 Materials and methods relating to protein aggregation in neurodegenerative disease
10/15/2003EP1352075A2 Maize yellow stripe1 and related genes
10/15/2003EP1352070A2 A fibrin/fibrinogen-binding conjugate
10/15/2003EP1352068A2 Bacillus thuringiensis insecticidal proteins
10/15/2003EP1352067A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/15/2003EP1352066A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/15/2003EP1352065A2 Polypetides and nucleic acids encoding same
10/15/2003EP1352064A2 Seleno-cysteine containing protein zsel1
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003EP1352062A2 Improved growth hormone molecules
10/15/2003EP1352056A2 Polypeptides
10/15/2003EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase
10/15/2003EP1352053A2 Method for processing dendritic cells and for activating macrophages with ru 41740
10/15/2003EP1351991A2 Ternary biomolecule/polymer/surface-based immobilization systems
10/15/2003EP1351987A2 Hybrid antibodies
10/15/2003EP1351986A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351984A2 Amidated glucagon-like peptide-1
10/15/2003EP1351983A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof
10/15/2003EP1351982A2 X ray crystal structures at 5.5 a resolution of functional complexes of the bacterial ribosome containing transfer rna and model messenger rnas
10/15/2003EP1351981A2 A virus causing respiratory tract illness in susceptible mammals
10/15/2003EP1351980A2 Peptides for activation and inhibition of delta pkc
10/15/2003EP1351979A1 Regulated activation of cell-membrane receptors by metal-chelating agonists
10/15/2003EP1351978A2 Retrovirus isolated from humans
10/15/2003EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/15/2003EP1351967A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2003EP1351841A2 Oil maintenance indicator
10/15/2003EP1351744A2 Erbb4 antagonists
10/15/2003EP1351711A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway
10/15/2003EP1351708A1 Therapeutic agent comprising a b-subunit of a protein toxin
10/15/2003EP1351704A2 Storage stable powder compositions of interleukin-4 receptor
10/15/2003EP1351703A2 Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation
10/15/2003EP1351702A1 Trem-1 splice variant for use in modifying immune responses
10/15/2003EP1351699A1 Methods for improved diagnosis and treatment of mycobacterial infections
10/15/2003EP1351648A2 Carrier vectors through an epithelium with tight junctions
10/15/2003EP1189627B1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
10/15/2003EP0805161B1 (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody
10/15/2003EP0796276B1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
10/15/2003EP0716591B1 USE OF ApoE FOR BINDING TAU AND MAP2c PROTEINS AND FOR TREATING ALZHEIMER'S DISEASE
10/15/2003EP0706568B1 Vertebrate apoptosis gene: compositions and methods
10/15/2003EP0689595B1 Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter
10/15/2003EP0585398B1 Hcv genomic sequences for diagnostics and therapeutics
10/15/2003CN1449446A Streptococcus antigens
10/15/2003CN1449445A Ev-vegf nucleic acids and polypeptides and methods of use
10/15/2003CN1449443A 真菌细胞壁合成基因 Fungal cell wall synthesis genes
10/15/2003CN1449441A Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone
10/15/2003CN1449440A Masp-2, a complement-fixing enzyme, and uses for it
10/15/2003CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/15/2003CN1449409A Promyostatin peptides and methods of using same
10/15/2003CN1449250A Novel insecticidal toxins derived from bacillus thuringiensis insecticidal crystal proteins
10/15/2003CN1448509A Human ICAM-1 extramembranous I-III domain gene expression product ,its prep. and application in radioimmunological technology
10/15/2003CN1448406A Human B lymphocyte stimulating factor mutant and constructing method and coding gene thereof
10/15/2003CN1448405A Human truncated recombination soluble TRAIL-170 protein and application for preparing tumour-curing medicine thereof
10/15/2003CN1448404A Human truncated recombination soluble TRAIL-180 protein and application for preparing tumour-curing medicine thereof
10/15/2003CN1448403A Human protein with cancer cell growth suppressing function and its coding sequence
10/15/2003CN1448402A Polypeptide-human anemia related protein 35.4 and polynucleotide for coding said polypeptide
10/15/2003CN1448401A Protein related to plant cell cycle and its coding gene
10/15/2003CN1448398A Cotton bollworm molt-regulating transcription factor cDNA and cloning method and recombination application thereof
10/15/2003CN1448065A Protein extracting and separating method from defatted cotton dregs
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/15/2003CN1124346C Novel yeast genes
10/15/2003CN1124343C Brain derived naurotrophic factor
10/15/2003CN1124342C Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor
10/15/2003CN1124339C Novel cell surface protein
10/15/2003CN1124283C Peptide, bronchodilator and blood flow ameliorant
10/15/2003CN1124282C Conformationally constrained backbone cyclized somatostatin analogs
10/15/2003CN1124159C Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants
10/14/2003US6632981 Transgenic plants and tissues with chimeric construction; gene expression control
10/14/2003US6632980 Chromosomally-integrated inactive replicon derived from geminiviruses and single-stranded RNA viruses; cis-acting viral elements for replication; target gene with regulatory sequence
10/14/2003US6632977 Transgenic animal whose expression of the opiate receptors is modified
10/14/2003US6632937 Nucleic acids and proteins from Cenarchaeum symbiosum
10/14/2003US6632935 Genome DNA of bacterial symbiont of aphids
10/14/2003US6632934 MORC gene compositions and methods of use
10/14/2003US6632929 Avidin derivatives and uses thereof